Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.49B | 3.57B | 3.32B | 2.55B | 2.26B |
Gross Profit | 848.00M | 857.40M | 763.40M | 583.50M | 550.10M |
EBITDA | 472.00M | 507.30M | 477.80M | 463.20M | 351.60M |
Net Income | 142.00M | 164.60M | 155.70M | 243.10M | 24.80M |
Balance Sheet | |||||
Total Assets | 4.58B | 4.85B | 4.07B | 3.91B | 3.05B |
Cash, Cash Equivalents and Short-Term Investments | 577.00M | 708.00M | 495.50M | 559.10M | 587.20M |
Total Debt | 1.82B | 2.00B | 1.67B | 1.59B | 1.16B |
Total Liabilities | 3.20B | 3.49B | 3.03B | 3.09B | 2.39B |
Stockholders Equity | 1.20B | 1.20B | 1.00B | 785.90M | 646.10M |
Cash Flow | |||||
Free Cash Flow | 288.00M | 320.20M | 77.10M | -343.90M | 162.10M |
Operating Cash Flow | 433.00M | 499.70M | 233.80M | -91.80M | 319.00M |
Investing Cash Flow | -154.00M | -482.00M | -199.70M | -128.90M | -137.90M |
Financing Cash Flow | -409.00M | 178.00M | -83.90M | 197.70M | -17.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £254.53M | 8.36 | 32.09% | 1.39% | 2.90% | 419.40% | |
75 Outperform | £215.57M | 12.83 | 38.77% | 5.03% | -3.56% | -5.13% | |
74 Outperform | £1.11B | 39.70 | 4.10% | 2.72% | -6.95% | -52.08% | |
73 Outperform | £571.63M | 20.71 | 8.04% | 4.37% | -7.30% | -59.71% | |
58 Neutral | HK$13.62B | 5.49 | -2.78% | 5.72% | 2.29% | -57.50% | |
55 Neutral | £1.05B | 25.26 | 4.21% | 6.82% | -5.74% | -75.29% | |
54 Neutral | £261.25M | ― | -6.40% | ― | -21.84% | 10.56% |
RHI Magnesita N.V. announced its total voting rights as of July 31, 2025, with an issued share capital of 47,298,594 ordinary shares, excluding 2,179,111 shares held in treasury. This announcement is crucial for shareholders and stakeholders as it determines the denominator for calculating notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, impacting how changes in shareholding interests are reported.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £3200.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita reported a challenging first half of 2025, with a 26% drop in adjusted EBITA to €141 million due to deferred industrial projects and a competitive pricing environment. Despite stable steel demand, the company faced pressure from low capacity utilization and rising costs, leading to a decrease in gross margin. Management anticipates a recovery in the second half through strategic actions, including price increases and cost savings, aiming for a full-year adjusted EBITA between €370 and €390 million. The company remains focused on growth through mergers and acquisitions, particularly in high-growth regions like India, Türkiye, and North America.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4400.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita announced it will release its half-year results for the period ending 30 June 2025 on 30 July 2025. The announcement will be accompanied by a webcast presentation for investors and analysts, highlighting the company’s ongoing commitment to transparency and engagement with stakeholders. This release is expected to provide insights into the company’s performance and strategic direction, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4400.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita announced the appointment of Janet Ashdown as a Non-Executive Director and Chair-elect of the Remuneration Committee at Synthomer Plc, effective from July 1, 2025. This strategic move highlights RHI Magnesita’s commitment to strengthening its governance and leadership, potentially enhancing its industry positioning and stakeholder confidence.
The most recent analyst rating on (GB:RHIM) stock is a Hold with a £4000.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita N.V. announced that as of May 31, 2025, its issued share capital comprises 47,294,191 ordinary shares, with an additional 2,183,514 shares held in treasury. This update is significant for shareholders and those with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, as it affects the calculation of their interests in the company.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita N.V. announced that a person discharging managerial responsibilities exercised share options over 6,017 ordinary shares, which were subsequently sold. The transaction was part of the company’s Long Term Incentive Plan, with shares transferred from the company’s treasury account. This move reflects the company’s adherence to its incentive plans and regulatory compliance, potentially impacting its stock liquidity and market perception.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.
RHI Magnesita announced the appointment of Jann Brown as a Non-Executive Director on its board, effective from May 22, 2025. This strategic move is expected to enhance the company’s governance and potentially strengthen its market position, reflecting its ongoing commitment to leadership and growth in the refractory industry.
The most recent analyst rating on (GB:RHIM) stock is a Buy with a £4150.00 price target. To see the full list of analyst forecasts on RHI Magnesita NV stock, see the GB:RHIM Stock Forecast page.